2023
Entrant Company
Category
Client's Name
Country / Region
Approximately 8% to 10% of actinic keratosis (AK) will develop into intraepithelial squamous cell carcinoma. When it comes to treating AK, research shows that dermatologists are very consistent and set in their ways because of their satisfaction with current treatments—from cryotherapy to topicals to the most commonly used photodynamic therapy (PDT) brand. Their satisfaction extends beyond clinical expectations and results to include financial aspects and fit with practice and patient flow.
AMELUZ® (aminolevulinic acid hydrochloride) topical gel, 10%, was the first and only PDT approved for field-directed treatment of AK and a clinical profile that delivered high clearance rates, but despite that, had experienced low awareness and slow uptake. This was due primarily to launching into a market that was dominated by entrenched behavior/mindsets and a complacent PDT market leader.
Entrant Company
Recruit Rooster
Category
Video - Recruitment (NEW)
Country / Region
United States
Entrant Company
AARP
Category
Publication - Annual Report
Country / Region
United States
Entrant Company
The N2 Company
Category
Advertising - Magazine Ad (Single)
Country / Region
United States
Entrant Company
LevLane
Category
Integrated Marketing - Integrated Marketing Campaign
Country / Region
United States